Morphic Ethical Equities Expands Share Buy-Back Program
Morphic Ethical Equities Fund Limited (ASX: MEC) has released the latest update on its on-market share buy-back program, highlighting the company's ongoing efforts to optimise capital allocation and deliver long-term value to shareholders. As of 23 June 2026, the company had repurchased a cumulative 1,581,661 ordinary shares, including 30,740 shares bought back on the previous trading day. The latest purchases were executed at AU$1.355 per share, with a total consideration of approximately AU$41,653 for the day. The buy-back activity forms part of the company’s capital management strategy and reflects management’s confidence in the fund’s underlying value.
The buy-back program allows MEC to repurchase up to 6,475,300 shares, representing 20% of shares on issue as approved by shareholders at the November 2025 Annual General Meeting. The program commenced on 20 November 2025 and is scheduled to continue until 19 November 2026. Following the latest transactions, approximately 4.89 million shares remain available for repurchase under the approved limit. The extension of the buy-back period and increased capacity provide MEC with continued flexibility to manage its capital structure and potentially improve returns for existing shareholders.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Morphic Ethical Equities Expands Share Buy-Back Program
Morphic Ethical Equities Fund Limited (ASX: MEC) has released the latest update on its on-market share buy-back program, highlighting the company's ongoing efforts to optimise capital allocation and deliver long-term value to shareholders. As of 23 June 2026, the company had repurchased a cumulative 1,581,661 ordinary shares, including 30,740 shares bought back on the previous trading day. The latest purchases were executed at AU$1.355 per share, with a total consideration of approximately AU$41,653 for the day. The buy-back activity forms part of the company’s capital management strategy and reflects management’s confidence in the fund’s underlying value.
The buy-back program allows MEC to repurchase up to 6,475,300 shares, representing 20% of shares on issue as approved by shareholders at the November 2025 Annual General Meeting. The program commenced on 20 November 2025 and is scheduled to continue until 19 November 2026. Following the latest transactions, approximately 4.89 million shares remain available for repurchase under the approved limit. The extension of the buy-back period and increased capacity provide MEC with continued flexibility to manage its capital structure and potentially improve returns for existing shareholders.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au